Pharmacokinetic study of cytosine arabinoside in patients with acute myelogeneous leukemia.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001086:Arabinofuranosyluracil / Q000008:administration & dosage / Q000378:metabolism; D003561:Cytarabine / Q000008:administration & dosage / Q000378:metabolism*; D003630:Daunorubicin / Q000008:administration & dosage; D006801:Humans; D007700:Kinetics; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008942:Mitoxantrone / Q000008:administration & dosage; D013866:Thioguanine / Q000008:administration & dosage
D003561:Cytarabine; D001086:Arabinofuranosyluracil; D008942:Mitoxantrone; D013866:Thioguanine; D003630:Daunorubicin